Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3,182,163
-
Total 13F shares
-
31,980,406
-
Share change
-
+1,201,463
-
Total reported value
-
$817,764,848
-
Price per share
-
$25.57
-
Number of holders
-
70
-
Value change
-
+$42,142,423
-
Number of buys
-
45
-
Number of sells
-
22
Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q4 2020
As of 31 Dec 2020,
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,980,406 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, FRAZIER MANAGEMENT LLC, New Leaf Venture Partners, L.L.C., BlackRock Inc., BOXER CAPITAL, LLC, Vivo Capital, LLC, VANGUARD GROUP INC, HIGHLINE CAPITAL MANAGEMENT, L.P., and MORGAN STANLEY.
This page lists
70
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.